This content is machine translated Hodgkin's disease Excess mortality after surviving disease: a search for causes Today, more than 80% of all patients with Hodgkin lymphoma can be cured, and in early stages even more than 90%. Nevertheless, the disease and its therapy have a significant…
View Post 3 min This content is machine translated Non-small cell lung cancer (NSCLC) New therapeutic option for metastatic NSCLC with METex14 skipping mutation. The growing understanding of tumor genetic mechanisms and the development of molecular diagnostics have enabled the development of targeted therapies, leading to significant advances in the treatment of lung cancer…
View Post 3 min This content is machine translated The somewhat different knowledge Where does the name “Sézary syndrome” actually come from? As a cutaneous T-cell lymphoma with an erythrodermic course, Sézary syndrome is a rare entity. Nevertheless, most physicians have encountered this prognostically unfavorable disease, at least in theory. This may…
View Post 3 min This content is machine translated European Lung Cancer Congress 2021 “Thoracic tumors remain unpredictable and dangerous” This year’s European Lung Cancer Congress (ELCC) was all about lung cancer. Prof. Oliver Gautschi, MD, Co-Chief Physician of the Clinic for Medical Oncology at the Lucerne Cantonal Hospital (LUKS),…
View Post 6 min This content is machine translated Lymphoma of the skin What’s new? Often, cutaneous lymphomas receive little attention. And yet, a lot has happened in recent years. Thus, innovative treatment options are also emerging for these rare conditions through new therapeutic options…
View Post 3 min This content is machine translated Monoclonal Gammopathy of Unclear Significance (MGUS) Identification of patients at risk Patients with monoclonal gammopathy of uncertain significance (MGUS) are at increased risk of developing certain forms of cancer. Regular checks allow changes to be detected at an early stage and…
View Post 2 min This content is machine translated Leukemic cutaneous T-cell lymphoma (L-CTCL) Sézary syndrome and mycosis fungoides: STAT5 as a therapeutic target? As the disease progresses, the tumor cells in leukemic variants of cutaneous T-cell lymphomas spread not only in the skin but also in the blood and lymph nodes. Although an…
View Post 4 min This content is machine translated SARS-CoV-2 Routine dermatological care in times of pandemic For about a year now, the COVID-19 pandemic has been shaping daily life in most medical and social settings. Among the multitude of pandemic aspects affecting the daily lives of…
View Post 6 min This content is machine translated Advanced renal cell carcinoma New points of attack under the microscope Even in the era of VEGF and checkpoint inhibitors, the prognosis for advanced renal cell carcinoma remains poor. The use of targeted therapies and immunotherapeutic approaches is difficult due to…
View Post 3 min This content is machine translated Skin cancer diagnostics New study on AI-assisted detection of basal cell carcinoma. Diagnostic systems using artificial intelligence are able to quickly and accurately classify abnormal skin lesions and offer great potential for improving diagnostic accuracy. This is also demonstrated by a new…
View Post 9 min This content is machine translated Uterine tumors State of the Art Endometrial carcinoma, uterine sarcomas, cervical carcinoma – uterine tumors are as diverse as the different cells found in the uterus. Accordingly, the management also differs significantly. Careful diagnostics for classification… CME-Test
